Literature DB >> 11852051

Anion exchanger isoform 2 operates in parallel with Na(+)/H(+) exchanger isoform 1 during regulatory volume decrease of human cervical cancer cells.

Meng Ru Shen1, Robert J Wilkins, Cheng Yang Chou, J Clive Ellory.   

Abstract

Intracellular pH (pH(i)) homeostasis was investigated in human cervical cancer SiHa cells undergoing regulatory volume decrease (RVD) to determine which transport systems were involved. Using isoform-specific primers, mRNA transcripts of Na(+)/H(+) exchanger isoform 1 (NHE1) and isoform 3 were identified by reverse transcriptase polymerase chain reaction (RT-PCR) and the results confirmed by Western immunoblotting. From anion exchanger isoforms 1-3 (AE1-3), only the mRNA transcript of AE2 was identified by RT-PCR and the identity was confirmed by digestion with a specific restriction endonuclease. SiHa cells loaded with the fluorescent dye 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein and resuspended in isotonic media showed a stable pH(i). In contrast, a gradual internal acidification took place following resuspension in hypotonic media. The NHE inhibitors, HOE694 (10 microM) and amiloride (1 mM), showed a similar potency in enhancing the rate and extent of the hypotonicity-induced internal acidification. The absence of extracellular Na(+) also substantially enhanced the acidification during RVD. These results suggest that internal acidification during RVD is mainly compensated by the operation of NHE1. Extracellular Cl(-) was critically necessary for the pH(i) acidification during RVD. The hypotonicity-induced acidification was significantly attenuated by 100 microM 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid, a concentration inhibiting more than 90% AE activity. This indicates that AE2 mediates a net Cl(-) influx with compensating HCO(3)(-) efflux during RVD. We conclude that AE2 operates in parallel with NHE1 to regulate pH(i) during RVD of human cervical cancer cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11852051     DOI: 10.1016/s0014-5793(01)03317-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Effect of NHE1 antisense gene transfection on the biological behavior of SGC-7901 human gastric carcinoma cells.

Authors:  Hai-Feng Liu; Xiao-Chun Teng; Jing-Chen Zheng; Gang Chen; Xing-Wei Wang
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

Review 2.  Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy.

Authors:  Jaleh Barar; Yadollah Omidi
Journal:  Bioimpacts       Date:  2013-12-10

Review 3.  The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters.

Authors:  Mark D Parker; Walter F Boron
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

4.  Roles of volume-activated Cl- currents and regulatory volume decrease in the cell cycle and proliferation in nasopharyngeal carcinoma cells.

Authors:  L X Chen; L Y Zhu; T J C Jacob; L W Wang
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

5.  Evidence that 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines.

Authors:  Delphine Denoyer; Nathalie Perek; Nathalie Le Jeune; Delphine Frere; Francis Dubois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-14       Impact factor: 9.236

6.  In vitro and in vivo evaluation of the influence of type III NaPi co-transporter activity during apoptosis on 99mTc-(V)DMSA uptake in the human leukaemic cell line U937.

Authors:  Delphine Denoyer; Nathalie Perek; Nathalie Le Jeune; Delphine Frere; Odile Sabido; Anthony Clotagatide; Francis Dubois
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-06-16       Impact factor: 9.236

7.  Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma.

Authors:  Atsushi Shiozaki; Shoichiro Hikami; Daisuke Ichikawa; Toshiyuki Kosuga; Hiroki Shimizu; Michihiro Kudou; Yuzo Yamazato; Toshiyuki Kobayashi; Katsutoshi Shoda; Tomohiro Arita; Hirotaka Konishi; Shuhei Komatsu; Takeshi Kubota; Hitoshi Fujiwara; Kazuma Okamoto; Mitsuo Kishimoto; Eiichi Konishi; Yoshinori Marunaka; Eigo Otsuji
Journal:  Oncotarget       Date:  2018-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.